A wonderful life or diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television

Health Communication

Volumn 22, Issue 3, 2007, Pages 241-252

  Macias, Wendy ^a   Pashupati, Kartik ^b   Lewis, Liza Stavchansky ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b SOUTHERN METHODIST UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36348930480     PISSN: 10410236     EISSN: None     Source Type: Journal    
DOI: 10.1080/10410230701626893     Document Type: Article

References (33)

1. Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (2000). Direct-to-consumer prescription drug advertising, 1989-1998: A content analysis of conditions, targets, inducements, and appeals. The Journal of Family Practice, 49, 329-335.
2. Bell, R. A., Wilkes, M. S., & Kravitz, R. L. (2000). The educational value of consumer-targeted prescription drug print advertising. Journal of Family Practice, 49, 1092-1098.
3. Bittar, C. (2002). Creating an r[sub x] monster. Brandweek, 43, 22-27.
4. Bittar, C. (2005). Prescription drugs. Brandweek, 46, SR26.
5. Brownfield, E. D., Bernhardt, J. M., Phan, J. L., Williams, M. V., & Parker, R. M. (2004). Direct-to-consumer drug advertisements on network television: An exploration of quantity, frequency, and placement. Journal of Health Communication, 9, 491-497.
6. Calfee, J. E. (2002). Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of Public Policy & Marketing, 21, 174-193.
7. Coney, S. (2002). Direct-to-consumer advertising of prescription pharmaceuticals: A consumer perspective from New Zealand. Journal of Public Policy & Marketing, 21, 213-222.
8. DTC has worked says FDA. (2001, June). Medical Marketing and Media, 34.
9. Food and Drug Administration. (1997, August 8). Draft guidance for industry; consumer directed broadcast advertisements; availability. In Department of Health and Human Services. Retrieved July 30, 2007, from http://www.fda.gov/cder/guidance/1804fhl.pdf.DocketNo. 970-0302.
10. Hensley, S. (2005a). In switch, J& J gives straight talk on drug risks in new ads. Wall Street Journal - Eastern Edition, p. B1.
11. Hensley, S. (2005b). Some drug makers are starting to curtail TV ad spending. Wall Street Journal - Eastern Edition, p. B1.
12. Huh, J., & Cude, B. J. (2004). Is the information "fair and balanced" in direct-to-consumer prescription drug websites? Journal of Health Communication, 9, 529-541.
13. Kaphingst, K. A., Dejong, W., Rudd, R. E., & Daltroy, L. N. (2004). A content analysis of direct-to-consumer television prescription drug advertisements. Journal of Health Communication, 9, 515-528.
14. Kopp, S. W., & Bang, H.-K. (2000). Benefit and risk information in prescription drug advertising: Review of empirical studies and marketing implications. Health Marketing Quarterly, 17(3), 39-56.
15. Kravitz, R. L. (2000). Direct-to-consumer advertising of prescription drugs: Implications for the patient-physician relationship. JAMA: Journal of the American Medical Association, 284, 22-44.
16. Lexchin, J., & Mintzes, B. (2002). Direct-to-consumer advertising of prescription drugs: The evidence says no. Journal of Public Policy & Marketing, 21, 194-201.
17. Macias, W., & Lewis, L. S. (2003). A content analysis of direct-to-consumer (DTC) prescription drug Web sites. Journal of Advertising, 32, 43.
18. Mintzes, B. (2001). An assessment of the health system impacts of direct-to-consumer advertising of prescription medications, Vol. i2: Literature review. Retrieved December 13, 2002, from http://www.chspr.ubc.ca//hpru/pdf/ dtca-v2-litreview.pdf
19. Mintzes, B. (2002). Direct to consumer advertising is medicalising normal human experience. BMJ: British Medical Journal, 324, 908-909.
20. Murphy, J. C. (2003). FDA warning letter re: Nda 20-539: Lamisil® (terbinafine hydrochloride) 250 mg tablets, macmis id#: 11692. Retrieved May 13, 2005, from http://www.fda.gov/cder/warn/2003/11692.pdf
21. No negative impact reported in wake of DTC advertising. (2001, August 6). Chemical Market Reporter, 15.
22. Parker, B. J., & Delene, L. M. (1999). The marketing of direct-to-consumer prescription drugs: An examination of advertising content. Journal of Promotion Management, 5(1), 37-55.
23. Paul, D. P., Handlin, A., & Stanton, A. D. A. (2002). Primary care physicians' attitudes toward direct-to-consumer advertising of prescription drugs: Still crazy after all these years. Journal of Consumer Marketing, 19, 564-574.
24. Riffe, D., Lacy, S., & Fico, F. (1998). Analyzing media messages: Using quantitative content analysis in research. Mahwah, NJ: Lawrence Erlbaum Associates, Inc.
25. Risker, D. C. (1996). The health belief model and consumer information searches: Toward an integrated model. Health Marketing Quarterly, 13(3), 13-26.
26. Roth, M. S. (1996). Patterns in direct-to-consumer prescription drug print advertising and their public policy. Journal of Public Policy & Marketing, 15, 63-75.
27. Stewart, D. W., & Furse, D. H. (1986). Effective television advertising: A study of 1000 commercials. Lexington, MA: Lexington Books.
28. Teinowitz, I. (2001). DTC regulation by FDA debated. Advertising Age, 72, 6.
29. Thomaselli, R. (2004). DTC agencies, clients clash. Advertising Age, 75, 1.
30. Wilkes, M. S., Bell, R. A., & Kravitz, R. L. (2000). Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Affairs, 19, 110-128.
31. Wogalter, M. S., Smith-Jackson, T. L., Mills, B. J., & Paine, C. S. (2002). The effects of print format in direct-to-consumer prescription drug advertisements on risk knowledge and preference. Drug Information Journal, 36, 693-705.
32. Wolfe, S. M. (2002). Direct-to-consumer advertising - education or emotion promotion? New England Journal of Medicine, 346, 524-526.
33. Woloshin, S., Schwartz, L. M., Tremmel, J., & Welch, H. G. (2001). Direct-to-consumer advertisements for prescription drugs: What are Americans being sold? Lancet, 358, 1141-1146.